1.
Claus I, Hoffmeister M, Strathmeyer S, Heelemann S, Remus C, Dammermann W, et al. Metabolomics for Distinguishing Cardiovascular Risk in Rheumatoid Arthritis Across Different Disease-Modifying Antirheumatic Drug Therapies. J Clin Med Res [Internet]. 2025 Feb. 13 [cited 2025 Feb. 22];17(2):89-96. Available from: https://jocmr.elmerjournals.com/jocmr/article/view/6145